Henrik Schultz
Impact in
- Genetics top 1%
- Glioma Diagnosis and Treatment
- Cancer Research top 10%
Papers in
- Surgery 26
- Testicular diseases and treatments 21
-
- Ovarian cancer diagnosis and treatment 8
- Co-authors
- Christine Marosi (2 shared papers)Ufuk Abacıoğlu (1 shared paper)Monika E. Hegi (2 shared papers)Benoît Lhermitte (1 shared paper)Johan Rosell (1 shared paper)Didier Frappaz (1 shared paper)Bjørn Henning Grønberg (2 shared papers)Roger Stupp (2 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (5 papers)Acta Oncologica (4 papers)Journal of Neuro-Oncology (2 papers)Neuro-Oncology (1 paper)Apmis (1 paper)
- Partner nations
- DenmarkSaudi ArabiaGermany
In The Last Decade
Henrik Schultz
60 papers receiving 2.4k citations
Henrik Schultz's Hit Papers
Peers
Comparison fields: 5 of 98
- Genetics 1.2k
- Cancer Research 304
- Reproductive Medicine 176
- Pulmonary and Respiratory Medicine 615
- Neurology 279
Countries citing papers authored by Henrik Schultz
This map shows the geographic impact of Henrik Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Schultz more than expected).
Fields of papers citing papers by Henrik Schultz
This network shows the impact of papers produced by Henrik Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Schultz. The network helps show where Henrik Schultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Henrik Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial Hit paper breakdown → | 2012 | 1004 |
| 2 | 2017 | 214 | |
| 3 | 1993 | 202 | |
| 4 | 1984 | 148 | |
| 5 | 2009 | 111 | |
| 6 | 2003 | 61 | |
| 7 | 1991 | 58 | |
| 8 | 2012 | 53 | |
| 9 | 1984 | 49 | |
| 10 | 1984 | 47 | |
| 11 | 2018 | 46 | |
| 12 | 1975 | 38 | |
| 13 | 1999 | 38 | |
| 14 | 1990 | 35 | |
| 15 | 1978 | 33 | |
| 16 | 1987 | 33 | |
| 17 | 1984 | 32 | |
| 18 | 1988 | 31 | |
| 19 | 2002 | 31 | |
| 20 | 2014 | 27 |
About Henrik Schultz
Henrik Schultz is a scholar working on Surgery, Reproductive Medicine, Genetics, Rheumatology and Pulmonary and Respiratory Medicine, having authored 63 papers that have together received 2.5k indexed citations. Recurring topics across this work include Testicular diseases and treatments (21 papers), Ovarian cancer diagnosis and treatment (8 papers), Glioma Diagnosis and Treatment (8 papers), Urologic and reproductive health conditions (7 papers), Sexual Differentiation and Disorders (5 papers), Sarcoma Diagnosis and Treatment (5 papers), Neuroblastoma Research and Treatments (4 papers) and Ecology, Conservation, and Geographical Studies (4 papers). The work is most often cited by research in Genetics (1.2k citations), Cancer Research (304 citations), Reproductive Medicine (176 citations), Pulmonary and Respiratory Medicine (615 citations) and Neurology (279 citations). Henrik Schultz has collaborated with scholars based in Denmark, Saudi Arabia and Germany. Frequent co-authors include Christine Marosi, Ufuk Abacıoğlu, Monika E. Hegi, Benoît Lhermitte, Johan Rosell, Didier Frappaz, Bjørn Henning Grønberg, Roger Stupp, Roger Henriksson and Annika Malmström. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Acta Oncologica, Journal of Neuro-Oncology, Neuro-Oncology and Apmis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.